Brief: Ocugen Announces Rare Pediatric Disease Designation Granted For Ocu410st—Modifier Gene Therapy For The Treatment Of Stargardt Disease
27/05/2025 13:06
May 27 (Reuters) - Ocugen Inc OCGN.O: OCUGEN ANNOUNCES RARE PEDIATRIC DISEASE DESIGNATION GRANTED FOR OCU410ST—MODIFIER GENE THERAPY FOR THE TREATMENT OF STARGARDT DISEASE OCUGEN INC: PLANS TO INITIATE PHASE 2/3 PIVOTAL CONFIRMATORY TRIAL IN FEW WEEKS WITH TARGET BLA IN 2027 Source text: ID:nGNX1fKD3L Further company coverage: OCGN.O ((Reuters.Briefs@thomsonreuters.com;))